Revolutionizing Regenerative Medicine for Hair Loss: Pelage Pharmaceuticals Secures $16.75M Series A Financing Led by GV February 27, 2024 Read More »
BrainStorm Cell Therapeutics Advances ALS Treatment with Phase 3b Trial of NurOwn® February 23, 2024 Read More »
